NEWS
-
Approval of Partial Change to the Indication of MyoMIBG® -I 123 Injection for Cardiac Scintigraphy for Patients with Parkinson’s Disease and Dementia with Lewy Bodies
-
PeptiDream and LinqMed Announce Strategic Partnership for the Development and Commercialization of 64Cu-ATSM in Japan(PeptiDream Inc.)
-
Approval of Insurance Coverage of AMYViD®, a PET Imaging Agent for Detecting Beta Amyloid
-
Acquisition of Assets for Radiopharmaceutical Data Solutions
-
Approval of partial change to the indication of AMYViD®, a PET imaging agent for detecting beta amyloid